Followers

December 28, 2023

Cytokinetics heart drug succeeds in closely watched study, shares surge

Cytokinetics said on Wednesday that its experimental heart disease drug met the main goal of a keenly awaited late-stage study, putting it on track to compete with a rival treatment from Bristol Myers Squibb.


No comments:

Post a Comment